TFA Therapeutics, Inc. (RAJAF) stock
RAJAFOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
$9.18+0.00 (0.00%)
Close on Oct 16, 2026Market cap –P/E –Yield –
TFA Therapeutics free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
TFA Therapeutics's free cash flow for the twelve months ending Dec 31, 2023 was $40.24K. For fiscal 2024 it was -$37.23K, down 192.5% from the year before.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | -$37.23K | -192.5% |
| FY2023 | Dec 31, 2023 | $40.24K | – |
| FY2022 | Dec 31, 2022 | -$321.85K | – |
| FY2021 | Dec 31, 2021 | -$465.36K | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2023 | Dec 31, 2023 | -$10.66K | – |
See a number that looks wrong?